In a series of previous postings (which start here), I bemoaned the fact that not one of the political candidates has picked up the issue raised by the fact that drug companies often hide data about side effects caused by medications they peddle, and do not report adverse reactions, even when these include fatalities. A new round of such sickening conduct is not as grievous, but is troubling enough. Where is the voice?
Antidepressant makers have not published the results of about one third of the drug tests they conducted to win government approval. A new analysis in the New England Journal of Medicine found that while 94% of the positive studies found their way to print, only 14% of those with disappointing results did. This form of highly selective publication misleads doctors and patients about the true effectiveness of the medications.
The new analysis has found that in published trials, 60 percent of those on drugs such as Paxil or Prozac reported a significant relief from depression, as opposed to 40 of those on placebo pills. But when one includes data from the unpublished trials, the benefits shrinks considerably. The drugs still outperform the placebos, but only modestly.
Read More